UFP Technologies, Inc. Deferred Tax Liabilities, Intangible Assets
UFP Technologies, Inc. (UFPT) had Deferred Tax Liabilities, Intangible Assets of $3.70 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross › Deferred Tax Liabilities, Goodwill and Intangible Assets
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-02-27
- 2025-12-31: Deferred Tax Liabilities, Intangible Assets $3.70M.
- 2024-12-31: Deferred Tax Liabilities, Intangible Assets $2.88M.
- 2023-12-31: Deferred Tax Liabilities, Intangible Assets $0.00.
- 2021-12-31: Deferred Tax Liabilities, Intangible Assets $0.00.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2025-12-31 | $3.70M 10-K · filed 2026-02-27 |
| 2024-12-31 | $2.88M 10-K · filed 2026-02-27 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-14 |
| 2020-12-31 | $34.00K 10-K · filed 2022-03-14 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-12 |
| 2012-12-31 | $69.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | $146.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |